Evidence map›Paper›PMID 30800654›Full record

ArticleFrontiers in chemistry2019

Illuminating the Anticancerous Efficacy of a New Fungal Chassis for Silver Nanoparticle Synthesis.

Nafe Aziz, Mohd Faraz, Mohd Asif Sherwani, Tasneem Fatma, Ram Prasad

Open access · goldAbstract read
In one paragraph

Article in Frontiers in chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 175 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Green Synthesis of Silver Nanoparticles UsingMolecules (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Role of Biosynthesized Ag-NPs UsingFrontiers in pharmacology · 2021
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Emerging Priorities for Microbiome Research.Frontiers in microbiology · 2020
    Review
  20. Biogenic Synthesis of Silver Nanoparticles UsingFrontiers in microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Nafe AzizDepartment of Biosciences, Jamia Millia Islamia, New Delhi, India.
Mohd FarazDepartment of Physics, Indian Institute of Technology Delhi, Haus Khas, New Delhi, India.
Mohd Asif SherwaniInterdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, India.
Tasneem FatmaDepartment of Biosciences, Jamia Millia Islamia, New Delhi, India.
Ram PrasadSchool of Environmental Science and Engineering, Sun Yat-Sen University, Guangzhou, China.
Jamia Millia Islamia · INAligarh Muslim University · INAmity University · INIndian Institute of Technology Delhi · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biogenic silver nanoparticles (Ag NPs) have supple platforms designed for biomedical and therapeutic intervention. Utilization of Ag NPs are preferred in the field of biomedicines and material science research because of their antioxidant, antimicrobial, and anticancerous activity along with their eco-friendly, biocompatible, and cost-effective nature. Here we present a novel fungus

Indexed as

antioxidant activitycancer cell lines (MCF-7, HeLa, HepG2)cytotoxic activityHEK-293Piriformospora indicasilver nanoparticles

Identifiers

PMID30800654
PMCPMC6375905
OpenAlexW2911512026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.